Search for Clinical Trial Results

Sponsored By

Papilledema - 16 Studies Found

Status Study
Completed Study Name: aICP in Glaucoma and Papilledema
Condition:
  • Open-angle Glaucoma
  • Papilledema

Date: 2015-03-23
Interventions: Device: Non-invasive ICP measurement (Vittamed 305) The non-invasive method is based on two-depth TCD te
Not yet recruiting Study Name: Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination
Condition: Papilledema Associated With Increased Intracranial Pressure
Date: 2016-12-05
Interventions: Device: Point of care ocular ultrasound
Recruiting Study Name: Antiacne Medications Pseudotumor Cerebri
Condition: Optic Disc Swelling
Date: 2014-04-07
Interventions: Other: Retinal nerve fibre layer measurement Measurement of retinal nerve fibre layer thickness using op
Completed Study Name: Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
Condition:
  • Uveitis
  • Glaucoma

Date: 2010-07-21
Terminated Study Name: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Condition:
  • Nervous System Malformations
  • Arthropathy, Neurogenic
  • Urtic
    Date: 2003-09-22
    Interventions: Drug: anakinra daily injection of subcutaneous injection
Not yet recruiting Study Name: OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension
Condition: Pediatric Idiopathic Intracranial Hypertension
Date: 2016-01-24
Interventions: Other: OCT Imaging
Recruiting Study Name: Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Condition:
  • Cataract
  • Retinal Edema
  • Inflammation

Date: 2013-04-16
Interventions:
  • Drug: Prolensa (bromfenac 0.07%)

Available Study Name: A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
Condition: Diabetic Macular Edema
Date: 2011-12-05
Interventions: Drug: Macugen (Pegaptanib Sodium) Pegaptanib sodium drug s
Not yet recruiting Study Name: Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF
Condition: Exudative Age Related Macular Degeneration
Date: 2017-02-24
Interventions: Drug: Ranibizumab Injection [Lucentis] intravitreal injection
Completed Study Name: Ozurdex for Macular Edema Post Membrane Peeling
Condition:
  • Epiretinal Membrane
  • Cellophane Maculopathy
  • Macular Edema Date: 2011-01-07
    Interventions:
    • Drug: Dexamethasone intravitre
Next >>>